$849 Million is the total value of ARMISTICE CAPITAL, LLC's 65 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| JILL | Exit | J JILL INC | $0 | – | -132,000 | -100.0% | -0.21% | – |
| AVXS | Exit | AVEXIS INC | $0 | – | -36,000 | -100.0% | -0.38% | – |
| OSTK | Exit | OVERSTOCK COM INC DEL | $0 | – | -184,000 | -100.0% | -0.38% | – |
| SFS | Exit | SMART & FINAL STORES INC | $0 | – | -364,000 | -100.0% | -0.42% | – |
| BURL | Exit | BURLINGTON STORES INC | $0 | – | -36,000 | -100.0% | -0.42% | – |
| AVEO | Exit | AVEO PHARMACEUTICALS INC | $0 | – | -1,600,000 | -100.0% | -0.45% | – |
| ANF | Exit | ABERCROMBIE & FITCH COcall | $0 | – | -500,000 | -100.0% | -0.79% | – |
| PINC | Exit | PREMIER INCcl a | $0 | – | -182,000 | -100.0% | -0.84% | – |
| CRI | Exit | CARTER INC | $0 | – | -78,000 | -100.0% | -0.88% | – |
| JCPNQ | Exit | PENNEY J C INC | $0 | – | -1,800,000 | -100.0% | -1.07% | – |
| SGYPQ | Exit | SYNERGY PHARMACEUTICALS DEL | $0 | – | -2,000,000 | -100.0% | -1.13% | – |
| LOCO | Exit | EL POLLO LOCO HLDGS INC | $0 | – | -700,000 | -100.0% | -1.24% | – |
| AET | Exit | AETNA INC NEW | $0 | – | -64,000 | -100.0% | -1.24% | – |
| DG | Exit | DOLLAR GEN CORP NEW | $0 | – | -140,000 | -100.0% | -1.29% | – |
| RXDX | Exit | IGNYTA INC | $0 | – | -1,000,000 | -100.0% | -1.32% | – |
| BBBY | Exit | BED BATH & BEYOND INC | $0 | – | -352,000 | -100.0% | -1.36% | – |
| BBY | Exit | BEST BUY INC | $0 | – | -200,000 | -100.0% | -1.46% | – |
| ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -100,000 | -100.0% | -1.55% | – |
| GCI | Exit | GANNETT CO INC | $0 | – | -1,536,000 | -100.0% | -1.71% | – |
| SEAS | Exit | SEAWORLD ENTMT INC | $0 | – | -1,000,000 | -100.0% | -2.07% | – |
| TPX | Exit | TEMPUR SEALY INTL INC | $0 | – | -350,000 | -100.0% | -2.38% | – |
| HAIN | Exit | HAIN CELESTIAL GROUP INC | $0 | – | -672,000 | -100.0% | -3.32% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC | 30 | Q3 2023 | 2.7% |
| SPDR S&P 500 ETF TR | 28 | Q3 2023 | 29.5% |
| MADRIGAL PHARMACEUTICALS INC | 27 | Q3 2023 | 2.9% |
| VANDA PHARMACEUTICALS INC | 26 | Q3 2021 | 9.4% |
| REGENERON PHARMACEUTICALS | 25 | Q3 2023 | 3.2% |
| ENERGIZER HLDGS INC NEW | 22 | Q2 2023 | 3.7% |
| ANTARES PHARMA INC | 21 | Q3 2020 | 6.6% |
| INCYTE CORP | 21 | Q3 2023 | 2.8% |
| VOYAGER THERAPEUTICS INC | 21 | Q3 2023 | 2.0% |
| BLUEBIRD BIO INC | 20 | Q4 2021 | 1.8% |
View ARMISTICE CAPITAL, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Avalo Therapeutics, Inc. | June 28, 2023 | 588,850 | 4.7% |
| Addex Therapeutics Ltd. | February 16, 2023 | 675,295 | 5.0% |
| Arcadia Biosciences, Inc. | February 14, 2023 | 2,675,409 | 10.0% |
| Avinger Inc | February 14, 2023 | 789,400 | 10.0% |
| Baudax Bio, Inc. | February 14, 2023 | 1,165,709 | 5.0% |
| BIORA THERAPEUTICS, INC. | February 14, 2023 | 12,989,648 | 5.7% |
| Bit Digital, Inc | February 14, 2023 | 3,161,889 | 3.7% |
| Bruush Oral Care Inc. | February 14, 2023 | 1,122,922 | 10.0% |
| CATALYST PHARMACEUTICALS, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| Clarus Therapeutics Holdings, Inc. | February 14, 2023 | 2,732,169 | 5.0% |
View ARMISTICE CAPITAL, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View ARMISTICE CAPITAL, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.